Skip to main content

Table 4 XPS data of the free ligands and their copper complexes

From: Synthesis, characterization, DNA binding interactions, DFT calculations, and Covid-19 molecular docking of novel bioactive copper(I) complexes developed via unexpected reduction of azo-hydrazo ligands

Core level

PCHD

Cu(PCHD)2]ClO4.H2O

PyCHD

[Cu(PyCHD)2]ClO4.H2O

BE

BE

BE

BE

C1s

284.08

–

–

–

C1s a

284.48

284.28

284.40

285.74

C1s b

285.88

285.72

285.51

287.63

C1s c

290.48

287.23

288.07

290.38

N1s

399.15

399.09

399.49

400.01

N1s a

400.56

400.42

400.39

399.44

N1s b

402.14

401.62

402.12

399.71

N1s c

403.77

–

401.44

–

N1s f

397.96

–

398.22

–

N1s h

–

–

403.56

–

O1s

–

531.25

–

532.94

O1s a

–

532.02

–

531.6

O1s b

–

532.02

–

528.63

Cl2 p a

–

199.60

–

208.70

Cl2 p b

–

196.27

–

204.73

Cl2 p c

–

207.10

–

207.11

Cl2 p d

–

201.12

–

–

Cu2p a

–

932.24

–

952.37

Cu2p b

–

952.39

–

932.47